Burford Brothers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
11,207
+105
+0.9% +$2.75K 0.1% 153
2026
Q1
$312K Buy
11,102
+310
+3% +$8.25K 0.13% 133
2025
Q4
$269K Buy
10,792
+763
+8% +$19.2K 0.11% 146
2025
Q3
$256K Sell
10,029
-675
-6% -$16.7K 0.11% 145
2025
Q2
$259K Buy
10,704
+26
+0.2% +$606 0.12% 139
2025
Q1
$271K Buy
10,678
+114
+1% +$2.98K 0.13% 126
2024
Q4
$280K Sell
10,564
-1,258
-11% -$34.1K 0.14% 125
2024
Q3
$342K Hold
11,822
0.18% 116
2024
Q2
$331K Sell
11,822
-50
-0.4% -$1.38K 0.19% 114
2024
Q1
$329K Buy
11,872
+561
+5% +$15.6K 0.22% 116
2023
Q4
$326K Buy
+11,311
New +$342K 0.23% 109

Other funds holding PFE

Burford Brothers's PFE Position: Q2 2026 in Review

Burford Brothers increased its Pfizer (PFE) stake by 0.95% in Q2 2026, buying an estimated $2.75K and bringing the position to 11,207 shares worth $270K. The position accounts for 0.1% of the portfolio, ranked #153.

Burford Brothers first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $342K in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Burford Brothers held 11,207 shares of Pfizer worth $270K as of Q2 2026.
  • Burford Brothers bought 105 Pfizer shares in Q2 2026, an estimated $2.75K.
  • Pfizer made up 0.1% of Burford Brothers's portfolio in Q2 2026, its #153 holding.
  • Burford Brothers first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Burford Brothers's Pfizer position peaked at $342K in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Burford Brothers's 13F filing for Q2 2026, filed 28 Jul 2026.